Related Experiment Videos
Is the treatment of CIN 2 always necessary in women under 25 years old?
Bree McAllum1, Peter H H Sykes, Lynn Sadler
1Department of Obstetrics and Gynecology, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand. mcabr965@student.otago.ac.nz
Objective:
The purpose of this study was to review the outcome of conservatively managed cervical intraepithelial neoplasia (CIN) 2 in women <25 years old.
Study Design:
This was a retrospective review that included women who were <25 years old with biopsy proven CIN2 between 2005 and 2009. Analysis was performed that compared women who had immediate treatment with women whose treatment was deferred >4 months. The primary outcome measure was spontaneous regression of CIN2. Secondary outcomes were treatment rates and loss to follow-up evaluation.
Results:
Of the 452 women who were identified, 256 women (57%) received immediate treatment; 157 women (35%) met the definition for conservative management, and 39 women (9%) had unknown subsequent management. Of the 157 women who were managed conservatively, 98 women (62%) showed spontaneous regression, with a median of 8 months observation. No conservatively managed women progressed to cancer.
Conclusion:
Based on the 62% regression rate in this study, routine treatment may not be necessary for all women with CIN2 who are <25 years old.
Related Concept Videos
Preventive Healthcare Services
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease V: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Inhibition of Cdk Activity